A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry.


Updates from The Motley Fool

Latest updates on Compugen from Fool.com.
Why Compugen Ltd. Shares Jumped

Compugen shares ascend to the heavens after disclosing initial data on one of its experimental im...

This Week in Biotech

EU approvals, FDA rejections, and the ongoing courtship of Onyx Pharmaceuticals highlight three o...



Stock Performance

View Interactive CGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Compugen.
Current Price: $4.35
Prev Close: $4.40
Open: $4.30
Bid: $4.00
Ask: $13.55
Day's Range: $4.25 - $4.40
52wk Range: $4.20 - $7.57
Volume: 87,883
Avg Vol 132,624
Market Cap: $222M
P/E (ttm): -7.10
EPS (ttm): ($0.62)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Compugen.
CAPS Rating 3 out of 5
 
59 Outperform
6 Underperform
CAPS All Stars
 
3 Outperform
2 Underperform

How do you think Compugen will perform against the market?



You pick for Compugen is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Anat Cohen-Dayag, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Compugen.

A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers